Charles B. Eaton mainly investigates Internal medicine, Physical therapy, Genome-wide association study, Women's Health Initiative and Body mass index. His Internal medicine research includes elements of Placebo, Endocrinology and Cardiology. He has researched Physical therapy in several fields, including Osteoarthritis, Relative risk, Confidence interval, Public health and Cohort.
His Confidence interval research incorporates themes from Odds ratio and Retrospective cohort study. His studies in Women's Health Initiative integrate themes in fields like Biomarker, Proportional hazards model and Gerontology. His Body mass index research is multidisciplinary, incorporating elements of Blood pressure and Risk factor.
His primary areas of study are Internal medicine, Osteoarthritis, Physical therapy, Women's Health Initiative and Body mass index. His work in Internal medicine covers topics such as Diabetes mellitus which are related to areas like Blood pressure. The various areas that Charles B. Eaton examines in his Osteoarthritis study include Odds ratio, Magnetic resonance imaging, Knee Joint and Radiography.
His Physical therapy research is multidisciplinary, relying on both Cohort study, Confidence interval, WOMAC, Cohort and Rheumatology. His Women's Health Initiative research incorporates elements of Incidence, Proportional hazards model and Gerontology. His research in Body mass index intersects with topics in Prospective cohort study, Surgery and Obesity.
Charles B. Eaton spends much of his time researching Internal medicine, Osteoarthritis, Women's Health Initiative, Heart failure and Cohort. His Internal medicine study frequently links to adjacent areas such as Cardiology. Charles B. Eaton interconnects Physical medicine and rehabilitation, Radiography, Magnetic resonance imaging, Physical therapy and Rheumatology in the investigation of issues within Osteoarthritis.
His research integrates issues of Diabetes mellitus, Cancer, Skin cancer and Ejection fraction in his study of Women's Health Initiative. His Heart failure research includes themes of Postmenopausal women, Incidence and Blood pressure. His studies deal with areas such as Obesity, Demography, Confidence interval, Proportional hazards model and Prospective cohort study as well as Body mass index.
His scientific interests lie mostly in Internal medicine, Osteoarthritis, Body mass index, Genome-wide association study and Demography. His studies link Placebo with Internal medicine. The concepts of his Osteoarthritis study are interwoven with issues in Radiography, Orthopedic surgery, Meniscus, Physical therapy and Rheumatology.
His Genome-wide association study research includes elements of Meta-analysis and Medical genetics. He has researched Demography in several fields, including Obesity, Blood pressure, Confidence interval, Socioeconomic status and Multilevel model. The Women's Health Initiative study combines topics in areas such as Prospective cohort study, Case-control study and Hyperlipidemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials
Jo Ann E. Manson;Rowan T. Chlebowski;Marcia L. Stefanick;Aaron K. Aragaki.
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
Mary F. Feitosa;Aldi T. Kraja;Daniel I. Chasman;Yun J. Sung.
PLOS ONE (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino.
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
D I Swerdlow;M V Holmes;K B Kuchenbaecker.
The Lancet (2012)
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Judith Hsia;Robert D Langer;Joann E Manson;Lewis Kuller.
JAMA Internal Medicine (2006)
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies
Lu Wang;Yiqing Song;JoAnn E. Manson;Stefan Pilz.
Circulation-cardiovascular Quality and Outcomes (2012)
Preoperative Hematocrit Levels and Postoperative Outcomes in Older Patients Undergoing Noncardiac Surgery
Wen-Chih Wu;Tracy L. Schifftner;William G. Henderson;Charles B. Eaton.
Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute Streptococcal Pharyngitis A Scientific Statement From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Michael A. Gerber;Robert S. Baltimore;Charles B. Eaton;Michael Gewitz.
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes.
The Lancet (2015)
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use
Mengzhen Liu;Yu Jiang;Robbee Wedow;Yue Li;Yue Li.
Nature Genetics (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: